Biliary innate immunity: Function and modulation

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Harada, Kenichi ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN; FRACTALKINE; INTERLEUKIN 17; INTERLEUKIN 8; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

BILE DUCT; BILE DUCT ATRESIA; BILE DUCT DISEASE; BILIARY TRACT DISEASE; CD4+ T LYMPHOCYTE; CHOLANGITIS; CHRONIC INFLAMMATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; INNATE IMMUNITY; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW; RNA VIRUS; SIGNAL TRANSDUCTION; TH17 CELL;

ANIMALS; ANTIGENS, BACTERIAL; BILIARY ATRESIA; BILIARY TRACT; CHOLANGITIS; CYTOKINES; DEFENSINS; EPITHELIAL-MESENCHYMAL TRANSITION; GALLSTONES; HUMANS; IMMUNITY, INNATE; LIVER CIRRHOSIS, BILIARY; PPAR GAMMA; TH17 CELLS; TOLL-LIKE RECEPTORS;

BACTERIA (MICROORGANISMS); DSRNA VIRUSES;

EID: 77956820580     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/373878     Document Type: Review

References (68)

1. Lemaitre B., Nicolas E., Michaut L., Reichhart J.-M., Hoffmann J. A., The dorsoventral regulatory gene cassette spatzle/Toll/Cactus controls the potent antifungal response in Drosophila adults Cell 1996 86 6 973 983
2. Akira S., Takeda K., Toll-like receptor signalling Nature Reviews Immunology 2004 4 7 499 511
3. Hugot J.-P., Chamaillard M., Zouali H., Lesage S., Czard J.-P., Belaiche J., Almer S., Tysk C., O'morain C. A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.-F., Sahbatou M., Thomas G., Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 2001 411 6837 599 603
4. Harada K., Ohira S., Isse K., Ozaki S., Zen Y., Sato Y., Nakanuma Y., Lipopolysaccharide activates nuclear factor-kappaB through Toll-like receptors and related molecules in cultured biliary epithelial cells Laboratory Investigation 2003 83 11 1657 1667
5. Hiramatsu K., Harada K., Tsuneyama K., Sasaki M., Fujita S., Hashimoto T., Kaneko S., Kobayashi K., Nakanuma Y., Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis Journal of Hepatology 2000 33 1 9 18
6. Osnes T., Sandstad O., Skar V., Osnes M., Lipopolysaccharides and beta-glucuronidase activity in choledochal bile in relation to choledocholithiasis Digestion 1997 58 5 437 443
7. Sasatomi K., Noguchi K., Sakisaka S., Sata M., Tanikawa K., Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis Journal of Hepatology 1998 29 3 409 416
8. Sheen-Chen S.-M., Chen W.-J., Eng H.-L., Sheen C.-W., Chou F.-F., Cheng Y.-F., Lee T.-Y., Bacteriology and antimicrobial choice in hepatolithiasis American Journal of Infection Control 2000 28 4 298 301
9. Harada K., Ozaki S., Kono N., Tsuneyama K., Katayanagi K., Hiramatsu K., Nakanuma Y., Frequent molecular identification of Campylobacter but not Helicobacter genus in bile and biliary epithelium in hepatolithiasis Journal of Pathology 2001 193 2 218 223
10. Nilsson H.-O., Taneera J., Castedal M., Glatz E., Olsson R., Wadstrm T., Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis Journal of Clinical Microbiology 2000 38 3 1072 1076
11. Sung J. Y., Costerton J. W., Shaffer E. A., Defense system in the biliary tract against bacterial infection Digestive Diseases and Sciences 1992 37 5 689 696
12. Xu L., Shen Z., Guo L., Fodera B., Keogh A., Joplin R., O'Donnell B., Aitken J., Carman W., Neuberger J., Mason A., Does a betaretrovirus infection trigger primary biliary cirrhosis? Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8454 8459
13. Tyler K. L., Sokol R. J., Oberhaus S. M., Le M., Karrer F. M., Narkewicz M. R., Tyson R. W., Murphy J. R., Low R., Brown W. R., Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts Hepatology 1998 27 6 1475 1482
14. Nilsson I., Kornilovs'ka I., Lindgren S., Ljungh., Wadstrm T., Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver disease Journal of Medical Microbiology 2003 52 11 949 953
15. Fox J. G., Dewhirst F. E., Shen Z., Feng Y., Taylor N. S., Paster B. J., Ericson R. L., Lau C. N., Correa P., Araya J. C., Roa I., Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis Gastroenterology 1998 114 4 I 755 763
16. Tsuneyama K., Harada K., Kono N., Hiramatsu K., Zen Y., Sudo Y., Gershwin M. E., Ikemoto M., Arai H., Nakanuma Y., Scavenger cells with Gram-positive bacterial lipoteichoic acid infiltrate around the damaged interlobular bile ducts of primary biliary cirrhosis Journal of Hepatology 2001 35 2 156 163
17. Burroughs A. K., Rosenstein I. J., Epstein O., Bacteriuria and primary biliary cirrhosis Gut 1984 25 2 133 137
18. Butler P., Valle F., Hamilton-Miller J. M. T., Brumfitt W., Baum H., Burroughs A. K., M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary cirrhosis and in patients with recurrent bacteriuria Journal of Hepatology 1993 17 3 408 414
19. Butler P., Hamilton-Miller J. M. T., McIntyre N., Burroughs A. K., Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups Gut 1995 36 6 931 934
20. Parikh-Patel A., Gold E. B., Worman H., Krivy K. E., Gershwin M. E., Risk factors for primary biliary cirrhosis in a cohort of patients from the United States Hepatology 2001 33 1 16 21
21. Haruta I., Hashimoto E., Kato Y., Kikuchi K., Kato H., Yagi J., Uchiyama T., Kobayash M., Shiratori K., Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis Autoimmunity 2006 39 2 129 135
22. Harada K., Tsuneyama K., Sudo Y., Masuda S., Nakanuma Y., Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation? Hepatology 2001 33 3 530 536
23. Gershwin M. E., Mackay I. R., Sturgess A., Coppel R. L., Identification and specificity of a cDNA encoding the 70 KD mitochondrial antigen recognized in primary biliary cirrhosis Journal of Immunology 1987 138 10 3525 3531
24. Shimoda S., Nakamura M., Ishibashi H., Hayashida K., Niho Y., HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases Journal of Experimental Medicine 1995 181 5 1835 1845
25. Kita H., Lian Z.-X., van de Water J., He X.-S., Matsumura S., Kaplan M., Luketic V., Coppel R. L., Ansari A. A., Eric Gershwin M., Identification of HLA-A2-restricted CD8+ cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells Journal of Experimental Medicine 2002 195 1 113 123
26. Morecki R., Glaser J. H., Cho S., Biliary atresia and reovirus type 3 infection The New England Journal of Medicine 1982 307 8 481 484
27. Morecki R., Glaser J. H., Johnson A. B., Kress Y., Detection of reovirus type 3 in the porta hepatis of an infant with extrahepatic biliary atresia: ultrastructural and immunocytochemical study Hepatology 1984 4 6 1137 1142
28. Riepenhoff-Talty M., Gouvea V., Evans M. J., Svensson L., Hoffenberg E., Sokol R. J., Uhnoo I., Greenberg S. J., Schkel K., Zhaori G., Fitzgerald J., Chong S., El-Yousef M., Nemeth A., Brown M., Piccoli D., Hyams J., Ruffin D., Rossi T., Detection of group C rotavirus in infants with extrahepatic biliary atresia Journal of Infectious Diseases 1996 174 1 8 15
29. Brown W. R., Sokol R. J., Levin M. J., Silverman A., Tamaru T., Lilly J. R., Hall R. J., Cheney M., Lack of correlation between infection with reovirus 3 and extrahepatic biliary atresia or neonatal hepatitis Journal of Pediatrics 1988 113 4 670 676
30. Bobo L., Ojeh C., Chiu D., Machado A., Colombani P., Schwarz K., Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia Pediatric Research 1997 41 2 229 234
31. Saito T., Shinozaki K., Matsunaga T., Ogawa T., Etoh T., Muramatsu T., Kawamura K., Yoshida H., Ohnuma N., Shirasawa H., Lack of evidence for reovirus infection in tissues from patients with biliary atresia and congenital dilatation of the bile duct Journal of Hepatology 2004 40 2 203 211
32. Rauschenfels S., Krassmann M., Al-Masri A. N., Verhagen W., Leonhardt J., Kuebler J. F., Petersen C., Incidence of hepatotropic viruses in biliary atresia European Journal of Pediatrics 2009 168 4 469 476
33. Al-Masri A. N., Flemming P., Rodeck B., Melter M., Leonhardt J., Petersen C., Expression of the interferon-induced Mx proteins in biliary atresia Journal of Pediatric Surgery 2006 41 6 1139 1143 (Pubitemid 43870076)
34. Riepenhoff-Talty M., Schaekel K., Clark H. F., Mueller W., Uhnoo I., Rossi T., Fisher J., Ogra P. L., Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice Pediatric Research 1993 33 4 I 394 399
35. Szavay P. O., Leonhardt J., Czech-Schmidt G., Petersen C., The role of reovirus type 3 infection in an established murine model for biliary atresia European Journal of Pediatric Surgery 2002 12 4 248 250
36. Takii Y., Nakamura M., Ito M., Yokoyama T., Komori A., Shimizu-Yoshida Y., Nakao R., Kusumoto K., Nagaoka S., Yano K., Abiru S., Ueki T., Matsumoto T., Daikoku M., Taniguchi K., Fujioka H., Migita K., Yatsuhashi H., Nakashima M., Harada M., Ishibashi H., Enhanced expression of type I interferon and Toll-like receptor-3 in primary biliary cirrhosis Laboratory Investigation 2005 85 7 908 920 (Pubitemid 41021299)
37. Harada K., Sato Y., Itatsu K., Isse K., Ikeda H., Yasoshima M., Zen Y., Matsui A., Nakanuma Y., Innate immune response to double-stranded RNA in biliary epithelial cells is associated with the pathogenesis of biliary atresia Hepatology 2007 46 4 1146 1154
38. Harada K., Isse K., Nakanuma Y., Interferon accelerates NF- B activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction Journal of Clinical Pathology 2006 59 2 184 190
39. Saito K., Nakanuma Y., Lactoferrin and lysozyme in the intrahepatic bile duct of normal livers and hepatolithiasis. An immunohistochemical study Journal of Hepatology 1992 15 1-2 147 153
40. Bals R., Wang X., Wu Z., Freeman T., Bafna V., Zasloff M., Wilson J. M., Human -defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung Journal of Clinical Investigation 1998 102 5 874 880
41. Sugiura H., Nakanuma Y., Secretory component and immunoglobulins in the intrahepatic biliary tree and peribiliary gland in normal livers and hepatolithiasis Gastroenterologia Japonica 1989 24 3 308 314
42. Harada K., Ohba K., Ozaki S., Isse K., Hirayama T., Wada A., Nakanuma Y., Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree Hepatology 2004 40 4 925 932
43. Isse K., Harada K., Nakanuma Y., IL-8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules Liver International 2007 27 5 672 680
44. Lefkowitch J. H., Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and 'cholangitis lenta' Human Pathology 1982 13 1 19 24
45. Isse K., Harada K., Zen Y., Kamihira T., Shimoda S., Harada M., Nakanuma Y., Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts Hepatology 2005 41 3 506 516
46. Shimoda S., Harada K., Niiro H., Taketomi A., Maehara Y., Tsuneyama K., Kikuchi K., Nakanuma Y., Mackay I. R., Gershwin M. E., Akashi K., CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis Hepatology 2010 51 2 567 575
47. Otte J.-M., Cario E., Podolsky D. K., Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells Gastroenterology 2004 126 4 1054 1070
48. Harada K., Isse K., Sato Y., Ozaki S., Nakanuma Y., Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M Liver International 2006 26 8 935 942
49. Harada K., Sato Y., Isse K., Ikeda H., Nakanuma Y., Induction of innate immune response and absence of subsequent tolerance to dsRNA in biliary epithelial cells relate to the pathogenesis of biliary atresia Liver International 2008 28 5 614 621
50. Kobayashi K., Hernandez L. D., Galn J. E., Janeway C. A. Jr., Medzhitov R., Flavell R. A., IRAK-M is a negative regulator of Toll-like receptor signaling Cell 2002 110 2 191 202
51. Takeda K., Akira S., Toll-like receptors in innate immunity International Immunology 2005 17 1 1 14
52. Thiery J. P., Epithelial-mesenchymal transitions in development and pathologies Current Opinion in Cell Biology 2003 15 6 740 746
53. Nakanuma Y., Kono N., Expression of vimentin in proliferating and damaged bile ductules and interlobular bile ducts in nonneoplastic hepatobiliary diseases Modern Pathology 1992 5 5 550 554
54. Rygiel K. A., Robertson H., Marshall H. L., Pekalski M., Zhao L., Booth T. A., Jones D. E. J., Burt A. D., Kirby J. A., Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease Laboratory Investigation 2008 88 2 112 123
55. Sato Y., Harada K., Ozaki S., Furubo S., Kizawa K., Sanzen T., Yasoshima M., Ikeda H., Sasaki M., Nakanuma Y., Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat American Journal of Pathology 2007 171 6 1859 1871
56. Daz R., Kim J. W., Hui J.-J., Li Z., Swain G. P., Fong K. S. K., Csiszar K., Russo P. A., Rand E. B., Furth E. E., Wells R. G., Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis Human Pathology 2008 39 1 102 115
57. Harada K., Sato Y., Ikeda H., Isse K., Ozaki S., Enomae M., Ohama K., Katayanagi K., Kurumaya H., Matsui A., Nakanuma Y., Epithelial-mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia Journal of Pathology 2009 217 5 654 664
58. Valds F., lvarez A. M., Locascio A., Vega S., Herrera B., Fernndez M., Benito M., Nieto M. A., Fabregat I., The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor in fetal rat hepatocytes Molecular Cancer Research 2002 1 1 68 78
59. Zavadil J., Bttinger E. P., TGF- and epithelial-to-mesenchymal transitions Oncogene 2005 24 37 5764 5774
60. Dooley S., Streckert M., Delvoux B., Gressner A. M., Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts Biochemical and Biophysical Research Communications 2001 283 3 554 562
61. Seki E., De Minicis S., sterreicher C. H., Kluwe J., Osawa Y., Brenner D. A., Schwabe R. F., TLR4 enhances TGF- signaling and hepatic fibrosis Nature Medicine 2007 13 11 1324 1332
62. Langrish C. L., Chen Y., Blumenschein W. M., Mattson J., Basham B., Sedgwick J. D., McClanahan T., Kastelein R. A., Cua D. J., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation Journal of Experimental Medicine 2005 201 2 233 240
63. Harada K., Shimoda S., Sato Y., Isse K., Ikeda H., Nakanuma Y., Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis Clinical and Experimental Immunology 2009 157 2 261 270
64. Acosta-Rodriguez E. V., Napolitani G., Lanzavecchia A., Sallusto F., Interleukins 1 and 6 but not transforming growth factor- are essential for the differentiation of interleukin 17-producing human T helper cells Nature Immunology 2007 8 9 942 949
65. Nakajima T., Kamijo Y., Tanaka N., Sugiyama E., Tanaka E., Kiyosawa K., Fukushima Y., Peters J. M., Gonzalez F. J., Aoyama T., Peroxisome proliferator-activated receptor protects against alcohol-induced liver damage Hepatology 2004 40 4 972 980
66. Nakajima A., Wada K., Miki H., Kubota N., Nakajima N., Terauchi Y., Ohnishi S., Saubermann L. J., Kadowaki T., Blumberg R. S., Nagai R., Matsuhashi N., Endogenous PPAR mediates anti-inflammatory activity in murine ischemia-reperfusion injury Gastroenterology 2001 120 2 460 469
67. Harada K., Isse K., Kamihira T., Shimoda S., Nakanuma Y., Th1 cytokine-induced downregulation of PPAR in human biliary cells relates to cholangitis in primary biliary cirrhosis Hepatology 2005 41 6 1329 1338
68. Okano H., Shiraki K., Inoue H., Yamanaka Y., Kawakita T., Saitou Y., Yamaguchi Y., Enokimura N., Yamamoto N., Sugimoto K., Murata K., Nakano T., 15-deoxy - 12-14- PGJ2 regulates apoptosis induction and nuclear factor- B activation via a peroxisome proliferator-activated receptor- -independent mechanism in hepatocellular carcinoma Laboratory Investigation 2003 83 10 1529 1539